T1	Participants 115 151	elderly patients with heart failure.
T2	Participants 372 523	study was performed at a single centre as an open randomised parallel-group study, patients being selected for inclusion from the outpatient population
T3	Participants 1137 1184	Sixty-one patients were randomised to treatment
T4	Participants 895 934	New York Heart Association (NYHA) class
